| Year |
Citation |
Score |
| 2020 |
Eleraky NE, Swarnakar NK, Mohamed DF, Attia MA, Pauletti GM. Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin. Aaps Pharmscitech. 21: 88. PMID 32016650 DOI: 10.1208/S12249-020-1618-2 |
0.339 |
|
| 2018 |
Allam AA, Potter SJ, Bud'ko SL, Shi D, Mohamed DF, Habib FS, Pauletti GM. Lipid-coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment. International Journal of Pharmaceutics. PMID 29981895 DOI: 10.1016/J.Ijpharm.2018.07.022 |
0.33 |
|
| 2016 |
Abd Ellah NH, Taylor L, Ayres N, Elmahdy MM, Fetih GN, Jones HN, Ibrahim EA, Pauletti GM. NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Cancer Gene Therapy. PMID 27125866 DOI: 10.1038/Cgt.2016.17 |
0.34 |
|
| 2013 |
Mu C, Dave N, Hu J, Desai P, Pauletti G, Bai S, Hao J. Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro. Journal of Microencapsulation. 30: 701-8. PMID 23517066 DOI: 10.3109/02652048.2013.778907 |
0.308 |
|
| 2012 |
Wang B, Gangwar S, Pauletti G, Siahaan T, Borchardt RT. Synthesis of an esterase-sensitive cyclic prodrug of a model hexapeptide having enhanced membrane permeability and enzymatic stability using a 3-(2'-hydroxy-4',6'-dimethylphenyl)-3,3-dimethyl propionic Acid promoiety. Methods in Molecular Medicine. 23: 53-69. PMID 21380891 DOI: 10.1385/0-89603-517-4:53 |
0.326 |
|
| 2012 |
Gangwar S, Pauletti GM, Siahaan TJ, Stella VJ, Borchardt RT. Synthesis of an esterase-sensitive cyclic prodrug of a model hexapeptide having enhanced membrane permeability and enzymatic stability using an acyloxyalkoxy promoiety. Methods in Molecular Medicine. 23: 37-51. PMID 21380890 DOI: 10.1385/0-89603-517-4:37 |
0.353 |
|
| 2011 |
Basha S, Vaidhyanathan S, Pauletti GM. Selection of peptide ligands for human placental transcytosis systems using in vitro phage display. Methods in Molecular Biology (Clifton, N.J.). 716: 141-56. PMID 21318904 DOI: 10.1007/978-1-61779-012-6_8 |
0.341 |
|
| 2010 |
Cho HS, Dong Z, Pauletti GM, Zhang J, Xu H, Gu H, Wang L, Ewing RC, Huth C, Wang F, Shi D. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. Acs Nano. 4: 5398-404. PMID 20707381 DOI: 10.1021/Nn101000E |
0.31 |
|
| 2010 |
Cui D, Zhang H, Sheng J, Wang Z, Toru A, He R, Tetsuya O, Gao F, Cho HS, Huth C, Hu H, Pauletti GM, Shi D. Effects of CdSe/ZnS quantum dots covered multi-walled carbon nanotubes on murine embryonicstem cells Nano Biomedicine and Engineering. 2: 236-244. DOI: 10.5101/Nbe.V2I4.P236-244 |
0.337 |
|
| 2008 |
Kawedia JD, Jiang M, Kulkarni A, Waechter HE, Matlin KS, Pauletti GM, Menon AG. The protein kinase A pathway contributes to Hg2+-induced alterations in phosphorylation and subcellular distribution of occludin associated with increased tight junction permeability of salivary epithelial cell monolayers. The Journal of Pharmacology and Experimental Therapeutics. 326: 829-37. PMID 18550693 DOI: 10.1124/Jpet.107.135798 |
0.359 |
|
| 2007 |
Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin. Chemotherapy. 53: 210-7. PMID 17356269 DOI: 10.1159/000100812 |
0.321 |
|
| 2005 |
Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM. Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 288: G533-40. PMID 15486347 DOI: 10.1152/Ajpgi.00248.2004 |
0.602 |
|
| 2003 |
D'Souza VM, Shertzer HG, Menon AG, Pauletti GM. High glucose concentration in isotonic media alters caco-2 cell permeability. Aaps Pharmsci. 5: E24. PMID 14621959 DOI: 10.1208/Ps050324 |
0.683 |
|
| 2003 |
D'Souza VM, Buckley DJ, Buckley AR, Pauletti GM. Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells. Journal of Pharmaceutical Sciences. 92: 594-603. PMID 12587121 DOI: 10.1002/Jps.10325 |
0.684 |
|
| 2003 |
D'Souza VM, Shertzer HG, Menon AG, Pauletti GM. High glucose concentration in isotonic media alters Caco-2 cell permeability Aaps Pharmsci. 5. |
0.679 |
|
| 2002 |
Plageman LR, Pauletti GM, Skau KA. Characterization of acetylcholinesterase in Caco-2 cells. Experimental Biology and Medicine (Maywood, N.J.). 227: 480-6. PMID 12094012 DOI: 10.1177/153537020222700712 |
0.315 |
|
| 1999 |
Gudmundsson OS, Pauletti GM, Wang W, Shan D, Zhang H, Wang B, Borchardt RT. Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability Pharmaceutical Research. 16: 7-15. PMID 9950272 DOI: 10.1023/A:1018828207920 |
0.374 |
|
| 1998 |
Sudoh M, Pauletti GM, Yao W, Moser W, Yokoyama A, Pasternak A, Sprengeler PA, Smith AB, Hirschmann R, Borchardt RT. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers Pharmaceutical Research. 15: 719-725. PMID 9619780 DOI: 10.1023/A:1011966918959 |
0.377 |
|
| 1997 |
T Borchardt R, Jeffrey Aubé, Siahaan TJ, Gangwar S, Pauletti GM. Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies. Advanced Drug Delivery Reviews. 27: 235-256. PMID 10837560 DOI: 10.1016/S0169-409X(97)00045-8 |
0.328 |
|
| 1997 |
Okumu FW, Pauletti GM, Vander Velde DG, Siahaan TJ, Borchardt RT. Effect of restricted conformational flexibility on the permeation of model hexapeptides across caco-2 cell monolayers Pharmaceutical Research. 14: 169-175. PMID 9090704 DOI: 10.1023/A:1012092409216 |
0.31 |
|
| 1997 |
Pauletti GM, Okumu FW, Borchardt RT. Effect of size and charge on the, passive diffusion of peptides across caco-2 cell monolayers via the paracellular pathway Pharmaceutical Research. 14: 164-168. PMID 9090703 DOI: 10.1023/A:1012040425146 |
0.321 |
|
| 1997 |
Pauletti GM, Gangwar S, Wang B, Borchardt RT. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of a phenylpropionic acid promoiety in a model hexapeptide Pharmaceutical Research. 14: 11-17. PMID 9034215 DOI: 10.1023/A:1012091014242 |
0.36 |
|
| 1997 |
Gangwar S, Pauletti GM, Siahaan TJ, Stella VJ, Borchardt RT. Synthesis of a novel esterase-sensitive cyclic prodrug of a hexapeptide using an (acyloxy)alkoxy promoiety Journal of Organic Chemistry. 62: 1356-1362. DOI: 10.1021/Jo961696A |
0.319 |
|
| 1997 |
Gangwar S, Pauletti GM, Wang B, Siahaan TJ, Stella VJ, Borchardt RT. Prodrug strategies to enhance the intestinal absorption of peptides Drug Discovery Today. 2: 148-155. DOI: 10.1016/S1359-6446(97)01011-8 |
0.335 |
|
| 1997 |
Gangwar S, Pauletti GM, Wang B, Siahaan TJ, Stella VJ, Borchardt RT. Novel esterase-sensitive cyclic prodrugs of a model hexapeptide having enhanced membrane permeability and enzymatic stability Pharmacochemistry Library. 28: 27-34. DOI: 10.1016/S0165-7208(97)80050-5 |
0.339 |
|
| 1996 |
Pauletti GM, Gangwar S, Okumu FW, Siahaan TJ, Stella VJ, Borchardt RT. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of an acyloxyalkoxy promoiety in a model hexapeptide Pharmaceutical Research. 13: 1615-1623. PMID 8956324 DOI: 10.1023/A:1016472119387 |
0.341 |
|
| 1996 |
Pauletti GM, Gangwar S, Knipp GT, Nerurkar MM, Okumu FW, Tamura K, Siahaan TJ, Borchardt RT. Structural requirements for intestinal absorption of peptide drugs Journal of Controlled Release. 41: 3-17. DOI: 10.1016/0168-3659(96)01352-1 |
0.369 |
|
| Show low-probability matches. |